88 related articles for article (PubMed ID: 31568163)
1. A Pharmaceutical Dispensing-based Index of Mortality Risk From Long-term Conditions Performed as well as Hospital Record-based Indices.
Stanley J; Doughty RN; Sarfati D
Med Care; 2020 Feb; 58(2):e9-e16. PubMed ID: 31568163
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of multimorbidity in New Zealand: a cross-sectional study using national-level hospital and pharmaceutical data.
Stanley J; Semper K; Millar E; Sarfati D
BMJ Open; 2018 May; 8(5):e021689. PubMed ID: 29794103
[TBL] [Abstract][Full Text] [Related]
3. The new measuring multimorbidity index predicted mortality better than Charlson and Elixhauser indices among the general population.
Stanley J; Sarfati D
J Clin Epidemiol; 2017 Dec; 92():99-110. PubMed ID: 28844785
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of the Cambridge Multimorbidity Score.
Payne RA; Mendonca SC; Elliott MN; Saunders CL; Edwards DA; Marshall M; Roland M
CMAJ; 2020 Feb; 192(5):E107-E114. PubMed ID: 32015079
[TBL] [Abstract][Full Text] [Related]
5. Development of a pharmacy-based comorbidity index for patients with cancer.
Sarfati D; Gurney J; Stanley J; Lim BT; McSherry C
Med Care; 2014 Jul; 52(7):586-93. PubMed ID: 24926705
[TBL] [Abstract][Full Text] [Related]
6. The M3 multimorbidity index outperformed both Charlson and Elixhauser indices when predicting adverse outcomes in people with diabetes.
Gurney JK; Stanley J; Sarfati D
J Clin Epidemiol; 2018 Jul; 99():144-152. PubMed ID: 29653198
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction.
Snow GL; Bledsoe JR; Butler A; Wilson EL; Rea S; Majercik S; Anderson JL; Horne BD
PLoS One; 2020; 15(5):e0233495. PubMed ID: 32437416
[TBL] [Abstract][Full Text] [Related]
8. Validation of PROFUND prognostic index over a four-year follow-up period.
Bernabeu-Wittel M; Moreno-Gaviño L; Ollero-Baturone M; Barón-Franco B; Díez-Manglano J; Rivas-Cobas C; Murcia-Zaragoza J; Ramos-Cantos C; Fernández-Moyano A;
Eur J Intern Med; 2016 Dec; 36():20-24. PubMed ID: 27491587
[TBL] [Abstract][Full Text] [Related]
9. Charlson Comorbidity Index is a predictor of outcomes in incident hemodialysis patients and correlates with phase angle and hospitalization.
Di Iorio B; Cillo N; Cirillo M; De Santo NG
Int J Artif Organs; 2004 Apr; 27(4):330-6. PubMed ID: 15163067
[TBL] [Abstract][Full Text] [Related]
10. CRONIGAL: Prognostic index for chronic patients after hospital admission.
Suárez-Dono J; Cervantes-Pérez E; Pena-Seijo M; Formigo-Couceiro F; Ferrón-Vidán F; Novo-Veleiro I; Del Corral-Beamonte E; Díez-Manglano J; Gude-Sampedro F; Pose-Reino A
Eur J Intern Med; 2016 Dec; 36():25-31. PubMed ID: 27745854
[TBL] [Abstract][Full Text] [Related]
11. Multimorbidity as specific disease combinations, an important predictor factor for mortality in octogenarians: the Octabaix study.
Ferrer A; Formiga F; Sanz H; Almeda J; Padrós G
Clin Interv Aging; 2017; 12():223-231. PubMed ID: 28184153
[TBL] [Abstract][Full Text] [Related]
12. Charlson Index is associated with one-year mortality in emergency department patients with suspected infection.
Murray SB; Bates DW; Ngo L; Ufberg JW; Shapiro NI
Acad Emerg Med; 2006 May; 13(5):530-6. PubMed ID: 16551775
[TBL] [Abstract][Full Text] [Related]
13. Unintentional injuries: A profile of hospitalization and risk factors for in-hospital mortality in Beijing, China.
Zhang M; Guo M; Guo X; Gao L; Zhou J; Bai X; Cui S; Pang C; Gao L; Xing B; Wang Y
Injury; 2019 Mar; 50(3):663-670. PubMed ID: 30709541
[TBL] [Abstract][Full Text] [Related]
14. Development and internal validation of a multimorbidity index that predicts healthcare utilisation using the Canadian Longitudinal Study on Aging.
Wang Z; Boulanger L; Berger D; Gaudreau P; Marrie RA; Potter B; Wister A; Wolfson C; Lefebvre G; Sylvestre MP; Keezer M
BMJ Open; 2020 Apr; 10(4):e033974. PubMed ID: 32241787
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Charlson Comorbidity Index in acutely hospitalized elderly adults: a prospective cohort study.
Frenkel WJ; Jongerius EJ; Mandjes-van Uitert MJ; van Munster BC; de Rooij SE
J Am Geriatr Soc; 2014 Feb; 62(2):342-6. PubMed ID: 24521366
[TBL] [Abstract][Full Text] [Related]
16. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.
Birim O; Kappetein AP; Bogers AJ
Eur J Cardiothorac Surg; 2005 Nov; 28(5):759-62. PubMed ID: 16157485
[TBL] [Abstract][Full Text] [Related]
17. The Australian Injury Comorbidity Index to Predict Mortality.
Fernando DT; Berecki-Gisolf J; Newstead S; Ansari Z
Ann Emerg Med; 2020 Mar; 75(3):339-353. PubMed ID: 31955941
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the recording of comorbidity in primary and secondary care by using the Charlson Index to predict short-term and long-term survival in a routine linked data cohort.
Crooks CJ; West J; Card TR
BMJ Open; 2015 Jun; 5(6):e007974. PubMed ID: 26048212
[TBL] [Abstract][Full Text] [Related]
19. The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices.
Yang CC; Fong Y; Lin LC; Que J; Ting WC; Chang CL; Wu HM; Ho CH; Wang JJ; Huang CI
Eur J Cardiothorac Surg; 2018 Jan; 53(1):235-240. PubMed ID: 29106506
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of alternative cardiovascular risk prediction equations for population health planning: a routine health data linkage study of 1.7 million New Zealanders.
Mehta S; Jackson R; Pylypchuk R; Poppe K; Wells S; Kerr AJ
Int J Epidemiol; 2018 Oct; 47(5):1571-1584. PubMed ID: 30010781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
